Gilead faces legal battles over HIV treatment and drug patents.
TL;DR Summary
The US Department of Health and Human Services is suing Gilead Sciences for infringing on patents obtained by the US Centers for Disease Control and Prevention (CDC) for an anti-HIV regimen. Gilead argues that the CDC's patents are invalid, and that the company invented the drugs used in the regimen. The trial, which is expected to last six days, will be heard in the US District Court in Delaware.
- Trial imminent for U.S. lawsuit against Gilead over HIV treatment The Washington Post
- Gilead, US set to clash at trial over PrEP drug patents FiercePharma
- Gilead, US square off in billion-dollar HIV drug patent trial Reuters
- A battle between Gilead and the U.S. government over patents on HIV prevention pills goes to trial STAT
- Dovato ad dispute between ViiV and Gilead escalates to feds after self-regulatory process fails FiercePharma
- View Full Coverage on Google News
Reading Insights
Total Reads
0
Unique Readers
11
Time Saved
3 min
vs 4 min read
Condensed
89%
626 → 69 words
Want the full story? Read the original article
Read on The Washington Post